PMV Pharmaceuticals snags $70m Series D

Cranbury, New Jersey-based PMV Pharmaceuticals, Inc., a precision oncology company, has closed $70 million in Series D financing.

Cranbury, New Jersey-based PMV Pharmaceuticals, Inc., a precision oncology company, has closed $70 million in Series D financing. The investors were Avoro Capital, RA Capital Management, Wellington Management Company, OrbiMed Advisors, Nextech Invest, Viking Global Investors, and Boxer Capital of Tavistock Group.

Source: Press Release